By Denny Jacob
Allurion Technologies shares rose after agreeing to a private placement with expected gross proceeds of $2.5 million that will extend its runway through early 2026.
The stock was up 13% to $3.37. The stock is down 96% in the last 52 weeks.
The developer of obesity treatments entered into a subscription agreement with funds affiliated with RTW Investments for the purchase and sale of 841,751 shares of its common stock at a purchase price of $2.97 a share. The agreement also includes an option to fund up to an additional $10 million in subsequent tranches.
The private placement is expected to close on or about Wednesday.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 14, 2025 13:42 ET (18:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.